Pinealon Mechanism of Action

Pinealon (EDR: Glu-Asp-Arg) is a synthetic tripeptide from the same research tradition as Epithalon, the 'peptide bioregulator' family developed by Vladimir Khavinson's group. The proposed mechanism is that short peptides like EDR bind complementarily to DNA promoter regions, modulating gene transcription directly, a hypothesis distinct from the receptor-agonist mechanisms most peptides in this catalog use, and one that remains contested and unreplicated outside the originating research group.

Pinealon-specific research centers on neuroprotective and cognitive-aging effects in animal models, positioned within the Khavinson group's broader work on organ-specific 'bioregulator' peptides (Pinealon for brain/pineal tissue, similar to how their other tripeptides target other organ systems).